Trials / Available
AvailableNCT04437004
Treatment of Dravet Syndrome With Fenfluramine (Expanded Access Protocol)
- Status
- Available
- Phase
- —
- Study type
- Expanded Access
- Enrollment
- —
- Sponsor
- University of California, Los Angeles · Academic / Other
- Sex
- All
- Age
- 2 Years
- Healthy volunteers
- —
Summary
The purpose of this research study is to (1) provide access to fenfluramine for patients with intractable epilepsy associated with Dravet syndrome, and (2) evaluate the safety of fenfluramine.
Detailed description
The purpose of this research study is to (1) provide access to fenfluramine for patients with intractable epilepsy associated with Dravet syndrome, and (2) evaluate the safety of fenfluramine.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Fenfluramine | The treatment plan for this Expanded Access Protocol is for patients with Dravet syndrome who do not qualify for participation in one of the ongoing ZX008 (fenfluramine hydrochloride) clinical trials. |
Timeline
- First posted
- 2020-06-18
- Last updated
- 2020-06-18
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT04437004. Inclusion in this directory is not an endorsement.